Skip to main content
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Clinical Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • Clinical Compendia
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • Clinical Compendia
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
Departments

Virtually Better Diabetes Care?

  1. Maria T. Vamvini,
  2. Joanne R. Dushay and
  3. Martin J. Abrahamson
  1. Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
  1. Corresponding author: Martin J. Abrahamson, mabraham{at}bidmc.harvard.edu
Clinical Diabetes 2019 Jul; 37(3): 284-286. https://doi.org/10.2337/cd18-0052
PreviousNext
  • Article
  • Info & Metrics
  • PDF
Loading

Despite growing awareness of the problem, the diabetes epidemic shows no signs of abating and continues to pose a public health problem of grave concern (1).

Nonpharmacologic interventions focused on lifestyle modifications, including diet and exercise, remain a major component of therapy. Individualized nutrition therapy has been shown to be effective for improvement of the metabolic profile and weight loss. However, most studies of popular diets are usually of short duration and have high attrition rates (15–50% within 1 year) (2). Adherence to any prescribed diet is a real challenge, especially when we are surrounded by easily accessible, processed food of high caloric and low nutritional value. It is therefore not surprising that lifestyle modification often fails, and as health care providers (HCPs), we find ourselves compelled to add more and more pharmacotherapies and often recommend metabolic surgery to achieve therapeutic goals. Indeed, despite significant advances in pharmacotherapy, there has been no significant change in the percentage of people who achieve therapeutic goals (3).

A key question that needs to be addressed is how HCPs can help patients adhere to a treatment plan that will enable them to achieve and sustain improvements in metabolic control. One of the most essential components of diabetes care is access to an HCP. There is a significant shortage of primary care providers and endocrinologists in the United States, with the rising number of patients with diabetes outstripping the number of HCPs (4).

Endocrinologists are asked to see more patients in less time, and new patients may have to wait for months to be seen. The problem is even worse for patients in remote areas, who must travel long distances to be seen. It is also commonly observed that patients lose their momentum along the path to improved metabolic health, despite their initial enthusiasm at a face-to-face office visit; this is not surprising given the paucity of time patients spend in direct contact with their HCPs. Thus, there is a need for ongoing support between office visits to help patients maintain their motivation, navigate day-to-day realities, overcome obstacles, and follow an individualized treatment plan, whether involving lifestyle modification or medication. Diabetes management is a long-term, high-touch endeavor.

The current model of health care delivery, with a shortage of HCPs and brief office visits, is inefficient and costly and fails many of our patients. The key to improving outcomes is ongoing education and coaching in the hope that patients will remain engaged and motivated to continue to manage their conditions optimally. Recent great advances in technology, such as telemedicine, present opportunities for a much-needed paradigm shift in health care delivery. Our increasingly hyper-connected society may be the optimal way to promote easy and frequent access to care for many patients at a relatively lower cost (5).

There is evidence that technological approaches to diabetes prevention and management are effective. Vadheim et al. (6) studied a group of patients in a remote frontier community and showed that patients’ participation in a group-based diabetes prevention lifestyle intervention through telehealth videoconferencing helped them achieve similar weight loss, physical activity, and diet goals and outcomes as patients who received onsite care. Similarly, Ciemins et al. (7) examined the effectiveness of a diabetes prevention program using videoconferencing technology and found similar weight loss in the telehealth and traditional care groups. In an earlier study (8), the same authors compared diabetes care outcomes of patients who had face-to-face office visits to those of patients in a remote area with limited access to HCPs and face-to-face visits who received medical care using telehealth technology, specifically videoconferencing. This study demonstrated effectiveness of telehealth on comprehensive diabetes management and outcomes that was similar to that of the traditional health care delivery model that includes office visits. Recent meta-analyses of randomized controlled trials using either teleconsultation or device-based telemonitoring also support the effectiveness of telemedicine interventions in achieving better A1C levels and in prevention of hypoglycemic events of moderate severity (9,10). Of note, whereas technology and telehealth in the form of teleconsultation and videoconferencing confer beneficial health outcomes, use of wearable devices such as physical activity monitors alone, without feedback and encouragement from an HCP, has been shown to be less effective for changing diet or physical activity behaviors compared to standard intervention (11). Taken together, it seems that telehealth models using applications that connect patients with their HCPs and facilitate ongoing education are most effective.

A recent study by Ramadas et al. (12) examined the effectiveness of a Web-based platform that provided patients in a developing country continuous education about dietary modification in conveying necessary dietary information, comprehension, and skills to participants. It found significant improvement in participants’ Dietary Knowledge, Attitude, and Behavior scores and a tendency of participants to have improved A1C. This recent study highlights the advantages of telemedicine in promoting patients’ diabetes education and providing support to this vulnerable patient population, helping them cope with the vast array of complexities and complications that can arise from diabetes.

Another recent study by Hallberg et al. (13) looked at the effectiveness and safety of a novel comprehensive care model for people with type 2 diabetes in a specific area in the United States, utilizing a nutritional intervention. The innovative approach was that the novel care model, which involved a very-low-carbohydrate diet, provided continuous supervision by a health coach and doctor and a high level of support to enable long-term maintenance of behavioral and metabolic change through continuous remote care. Patients in the novel care group had access to a Web-based software application for biomarker reporting and monitoring, education, and communication with a remote care team. The authors reported a significant decline in A1C, a 12% weight loss, and reduction in medication use in the novel care model group compared to a group of patients undergoing usual care. Most impressive was the relatively small attrition rate; 83% of the participants in the novel care model group were retained through 1 year. The authors attributed this success to improved patient perceptions of favorable health outcomes through individualized continuity of care, close relationships with health coaches, ongoing education, biometric feedback, and peer support. The intervention in this study was a ketogenic diet that is typically very difficult to maintain. However, most participants achieved and maintained nutritional ketosis through 1 year. More than the specific dietary intervention, the success story here is the novel approach to treating a chronic disease, which requires a high degree of ongoing support.

Although the use of telehealth is promising, there are many challenges that need to be considered. There is a concern about protecting the privacy of health information. In a world in which cybercrime is a palpable reality, it is important that patient data and electronic encounters be protected when Web-based applications are used. In addition, although younger generations are comfortable navigating the digital world, older patients may find it overwhelming to engage in virtual care. Development of user-friendly applications might be the solution to this barrier. There is also concern that telemedicine may compromise the directness of in-person physical encounters and partially jeopardize the nature of physician-patient relationships (14). Some studies have shown that home telemedicine programs are cost-effective; however, detailed cost data are incomplete, and a comprehensive analysis of the cost of this type of health care delivery is needed (15). This information is crucial and will help us integrate telemedicine into the current model of health care delivery, particularly if cost-effectiveness of larger-scale applications can be demonstrated and if the new approaches provide fair compensation for this type of care.

Considering the poor health outcomes linked to diabetes, we should embrace the advances of modern technology and employ them to provide innovative therapeutic solutions to manage chronic diseases such as diabetes. Telehealth technology combining teleconsultations, videoconferencing with health coaches, educational sessions, and use of data from wearable devices such as physical activity monitors or continuous glucose monitoring systems could help our patients feel more connected to their HCPs, provide access to care that is literally “one click away,” and encompass ongoing education, all of which will lead to better adherence to lifelong treatments and lifestyle changes.

Acknowledgments

Duality of Interest

No potential conflicts of interest relevant to this article were reported.

Author Contributions

M.T.V. reviewed the literature and wrote the initial draft of the manuscript. J.R.D. edited and revised the manuscript. M.J.A. supervised and edited the manuscript. M.J.A. is the guarantor of this work and, as such, takes responsibility for the integrity of the presented data.

  • © 2019 by the American Diabetes Association.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See www.diabetesjournals.org/content/license for details.

References

  1. 1.↵
    1. Centers for Disease Control and Prevention
    . National diabetes statistics report, 2017. Available from www.cdc.gov/diabetes/data/statistics/statistics-report.html. Accessed 6 June 2018
  2. 2.↵
    1. Greenberg I,
    2. Stampfer MJ,
    3. Schwarzfuchs D,
    4. Shai I,
    5. Group D
    . Adherence and success in long-term weight loss diets: the Dietary Intervention Randomized Controlled Trial (DIRECT). J Am Coll Nutr 2009;28:159–168
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Scheen AJ
    . Pharmacological management of type 2 diabetes: what’s new in 2017? Expert Rev Clin Pharmacol 2017;10:1383–1394
    OpenUrl
  4. 4.↵
    1. Vigersky RA,
    2. Fish L,
    3. Hogan P, et al.
    The clinical endocrinology workforce: current status and future projections of supply and demand. J Clin Endocrinol Metab 2014;99:3112–3121
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Banbury A,
    2. Nancarrow S,
    3. Dart J,
    4. Gray L,
    5. Parkinson L
    . Telehealth interventions delivering home-based support group videoconferencing: systematic review. J Med Internet Res 2018;20:e25
    OpenUrl
  6. 6.↵
    1. Vadheim LM,
    2. McPherson C,
    3. Kassner DR, et al.
    Adapted Diabetes Prevention Program lifestyle intervention can be effectively delivered through telehealth. Diabetes Educ 2010;36:651–656
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Ciemins EL,
    2. Coon PJ,
    3. Coombs NC,
    4. Holloway BL,
    5. Mullette EJ,
    6. Dudley WN
    . Intent-to-treat analysis of a simultaneous multisite telehealth diabetes prevention program. BMJ Open Diabetes Res Care 2018;6:e000515
    OpenUrl
  8. 8.↵
    1. Ciemins E,
    2. Coon P,
    3. Peck R,
    4. Holloway B,
    5. Min SJ
    . Using telehealth to provide diabetes care to patients in rural Montana: findings from the promoting realistic individual self-management program. Telemed J E Health 2011;17:596–602
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Tchero H,
    2. Kangambega P,
    3. Briatte C,
    4. Brunet-Houdard S,
    5. Retali GR,
    6. Rusch E
    . Clinical effectiveness of telemedicine in diabetes mellitus: a meta-nalysis of 42 randomized controlled trials. Telemed J E Health. Epub ahead of print on 20 August 2018 (doi: 10.1089/tmj.2018.0128)
  10. 10.↵
    1. Hu Y,
    2. Wen X,
    3. Wang F, et al.
    Effect of telemedicine intervention on hypoglycaemia in diabetes patients: a systematic review and meta-analysis of randomised controlled trials. J Telemed Telecare 2018:1357633X18776823
  11. 11.↵
    1. Jakicic JM,
    2. Davis KK,
    3. Rogers RJ, et al.
    Effect of wearable technology combined with a lifestyle intervention on long-term weight loss: the IDEA randomized clinical trial. JAMA 2016;316:1161–1171
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Ramadas A,
    2. Chan CKY,
    3. Oldenburg B,
    4. Hussein Z,
    5. Quek KF
    . Randomised-controlled trial of a web-based dietary intervention for patients with type 2 diabetes: changes in health cognitions and glycemic control. BMC Public Health 2018;18:716
    OpenUrl
  13. 13.↵
    1. Hallberg SJ,
    2. McKenzie AL,
    3. Williams PT, et al.
    Effectiveness and safety of a novel care model for the management of type 2 diabetes at 1 year: an open-label, non-randomized, controlled study. Diabetes Ther 2018;9:583–612
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Wildenbos GA,
    2. Peute LW,
    3. Jaspers MW
    . Impact of patient-centered eHealth applications on patient outcomes: a review on the mediating influence of human factor issues. Yearb Med Inform 2016:113–119
  15. 15.↵
    1. Michaud TL,
    2. Zhou J,
    3. McCarthy MA,
    4. Siahpush M,
    5. Su D
    . Costs of home-based telemedicine programs: a systematic review. Int J Technol Assess Health Care 2018;34:410–418
    OpenUrl
PreviousNext
Back to top
Clinical Diabetes: 37 (3)

In this Issue

July 2019, 37(3)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Clinical Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Virtually Better Diabetes Care?
(Your Name) has forwarded a page to you from Clinical Diabetes
(Your Name) thought you would like to see this page from the Clinical Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Virtually Better Diabetes Care?
Maria T. Vamvini, Joanne R. Dushay, Martin J. Abrahamson
Clinical Diabetes Jul 2019, 37 (3) 284-286; DOI: 10.2337/cd18-0052

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Virtually Better Diabetes Care?
Maria T. Vamvini, Joanne R. Dushay, Martin J. Abrahamson
Clinical Diabetes Jul 2019, 37 (3) 284-286; DOI: 10.2337/cd18-0052
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Acknowledgments
    • References
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

Departments

  • Transitioning to Fixed-Ratio Combination Therapy: Five Frequently Asked Questions Health Care Providers Should Anticipate From Their Patients
  • Gvoke HypoPen: An Auto-Injector Containing an Innovative, Liquid-Stable Glucagon Formulation for Use in Severe Acute Hypoglycemia
  • Timely News and Notes for Primary Care Providers from the American Diabetes Association
Show more Departments

Commentary

  • Expanding Flash Continuous Glucose Monitoring Technology to a Broader Population
  • Reflection (With Some Coaching) on a Quality Improvement Initiative: Finding Our Collective Voice Along the Journey
  • Suggestions to Overcome Racial Inequities Among Health Care Professionals
Show more Commentary

Similar Articles

Navigate

  • Current Issue
  • Papers in Press
  • Abridged Standards of Care
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Diabetes Care
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Clinical Diabetes Print ISSN: 0891-8929, Online ISSN: 1945-4953.